Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.86
-0.19 (-3.14%)
At close: Dec 20, 2024, 4:00 PM
5.80
-0.06 (-1.02%)
After-hours: Dec 20, 2024, 7:58 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $497.74 million as of December 20, 2024. Its market cap has increased by 18.28% in one year.
Market Cap
497.74M
Enterprise Value
126.27M
1-Year Change
18.28%
Ranking
Category
Stock Price
$5.86
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $497.74M, an increase of 246.59%. That is a compound annual growth rate of 37.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 497.74M | 24.11% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Semler Scientific | 512.07M |
| Phathom Pharmaceuticals | 509.41M |
| Talkspace | 503.39M |
| Auna S.A. | 501.16M |
| EyePoint Pharmaceuticals | 498.14M |
| Cartesian Therapeutics | 489.30M |
| Third Harmonic Bio | 488.43M |
| Verve Therapeutics | 485.97M |